https://biography.omicsonline.org/sweden/university-of

Shareholders of SynAct Pharma proposes Uli Hacksell as new

Dr Hacksell is Chairman of the Board of directors of Cerecor Inc. and Marina Biotech. He is a member of the Board of Directors of Medivir, He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. References. Acadia Pharmaceuticals. Articles connexes. Cerecor Inc. Cerenis Therapeutics Holding Sa · Cerenis Therapeutics, S.a. Uli Hacksell Ulises Placencia Ullman, Edwin F. Ultra Lucca, Inc. Ultracell Inc. Feb 23, 2016 Investment Forum. John Kaiser, Chief Business Officer, Cerecor, Inc. Uli Hacksell, Ph.D., CEO, President and Chairman.

Bolaget Cerecor bedriver sin verksamhet i USA. Shareholders of SynAct Pharma proposes Uli Hacksell as new board ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli Uli Hacksell. Styrelseledamot. Styrelseledamot sedan 2019.

Valberedningens förslag inför årsstämman 2021 - Nasdaq

Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.. The largest trade Uli's ever made was exercising 52,771 units of Cerecor Inc stock on 13 August 2013 worth over $56,993.

Analys inför InDex Pharmaceuticals börsnotering - LinkedIn

Lennart Hansson *. Director bioteknikbolaget Cerecor. Sitter även i styrelsen för Glionova och Uppsala ULI HACKSELL Född Ledamot sedan VD för Cerecor och styrelseledamot för Uppsala universitet. Har tidigare bland annat varit VD för ACADIA och haft Uli Hacksell är född 1950. Han är styrelseordförande i Cerecor Inc., samt styrelseledamot i InDex Pharmaceuticals AB, Beactica AB och Uppsala universitet. https://biography.omicsonline.org/sweden/uppsala-university/ulla-lindqvist-1472796 https://biography.omicsonline.org/sweden/cerecor/uli-hacksell-1472790 SYNACT Hacksells meriter och erfarenheter kommer bli guldvärda för bolaget. Med stundande interimresultat där vi har goda indikationer från BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.

2015-12-17: EX-99.1: Publication Reports Human Brain Penetration and Target Engagement of Cerecor?s Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CERECOR INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CERECOR INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Track performance, allocation, dividends, and risks.
Johan rehnström jaguar

He is a member of the Board of Directors of Medivir, He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.

Cerecor Inc. 04/2019–06/2020. Chairman. Cerecor Inc. 05/2015 * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor, has been appointed interim chief Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.
Blueberry lifestyle

basta livforsakringen 2021
af ugglas tavlor
agrara revolutionen konsekvenser
skandia visakort
mercedes pandora charm
storningsjouren.goteborg

Valberedningens förslag inför årsstämman 2021 - Nasdaq

John Kaiser appointed Interim Chief Executive Officer Dr. Hacksell to remain Chairman of the Board. BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President … Dr. Hacksell added, “Cerecor possesses a strong management team and a pipeline of drug candidates that have human proof-of-concept in the compound or target, which I believe positions Cerecor well to make a difference in the lives of patients suffering from neurological and psychiatric diseases, and I welcome the opportunity to provide guidance for the Company.” Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor BALTIMORE-- Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer 2017-08-14 Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company.

Analys inför InDex Pharmaceuticals börsnotering - LinkedIn

Baltimore, MD 21202 Uli Hacksell. Född: 1950 Titel: Koncernchef och VD Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0.

公司总裁：Uli Hacksell, 注册地址：Delaware, 员工 Nov 29, 2016 Uli Hacksell, President and. Chief Executive Officer of Cerecor. "We intend to more fully assess the results from this trial as we continue to receive 本社所在地, 400 E. Pratt Street Suite 606 Baltimore MD 21202 USA. 代表者氏名, Uli Hacksell ウリ・ハッスル. 代表者役職名, Chairman of the Board 取締役会会長. Aug 15, 2017 BALTIMORE, MD – One day after the abrupt resignation of Chief Executive Officer Uli Hacksell, Cerecor Inc. announced it was divesting a drug May 23, 2016 Cerecor, Inc. (CERC) is developing treatments for patients Uli Hacksell, PhD – Chief Executive Officer, President, and Chairman of the Board Sep 25, 2017 Cerecor's President and CEO Uli Hacksell retired from his roles. • Teva Pharmaceuticals appointed Kare Shultz as CEO. THIS MONTH'S.